All Articles

Editorial Commentary 
St. Gallen International Breast Cancer Conferences & Consensus
Beat Thürlimann
Translational Breast Cancer Research  
2024;
5:
22  
(30 July 2024) 
PDF Full Text (987) COI Form Open Access Get Permission
Review Article 
Breast cancer in pregnancy: a comprehensive review of diagnosis, management, and outcomes
Anam Mumtaz, Noor Otey, Bushra Afridi, Hazem Khout
Translational Breast Cancer Research  
2024;
5:
21  
(30 July 2024) 
PDF Full Text (1813) Peer Review File COI Form Open Access Get Permission
Review Article 
A narrative review: research progress of adjuvant intensive endocrine therapy for early breast cancer
Hunan Ye, Guang Lin, Xiaojia Wang
Translational Breast Cancer Research  
2024;
5:
20  
(30 July 2024) 
PDF Full Text (1542) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Original Article 
Matched-pair long-term survival analysis of male and female patients with breast cancer: a population-based study
Miao Mo, Xiaoshuang Feng, Chunxiao Wu, Yangming Gong, Jie Shen, Yulian He, Changming Zhou, Zezhou Wang, Chen Fu, Ying Zheng
Translational Breast Cancer Research  
2024;
5:
19  
(30 July 2024) 
PDF Full Text (886) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical Practice Guideline 
Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024
Jianbin Li, Chunfang Hao, Kun Wang, Jian Zhang, Jiayi Chen, Yueping Liu, Jianyun Nie, Min Yan, Qiang Liu, Cuizhi Geng, Xiaojia Wang, Haibo Wang, Shusen Wang, Jiong Wu, Yongmei Yin, Erwei Song, Zefei Jiang
Translational Breast Cancer Research  
2024;
5:
18  
(30 July 2024) 
PDF Full Text (4273) Peer Review File COI Form Open Access Get Permission
Case Report 
The need for a holistic guide to prevent and manage radiation dermatitis in patients’ with breast cancer: a case report
Deborah Witt Sherman
Translational Breast Cancer Research  
2024;
5:
17  
(30 April 2024) 
PDF Full Text (1487) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Editorial Commentary 
New role for GCH1 in cancer
Shane J. F. Cronin
Translational Breast Cancer Research  
2024;
5:
16  
(30 April 2024) 
PDF Full Text (1003) Peer Review File COI Form Open Access Get Permission
Editorial Commentary 
Metabolomics combined with mathematical analysis reveals metabolic pathways specific to metastatic cancers
Shinya Sato, Toshinari Yamashita
Translational Breast Cancer Research  
2024;
5:
15  
(30 April 2024) 
PDF Full Text (646) Peer Review File COI Form Open Access Get Permission
Review Article 
Breast fat grafting and cancer: a systematic review of the science behind enhancements and concerns
Denis Souto Valente, Pedro Bins Ely, Lucas Kieling, Ana Terezinha Konzen, Lucas Pastori Steffen, Gloria Sulczinski Lazzaretti, Rafaela Koehler Zanella
Translational Breast Cancer Research  
2024;
5:
14  
(30 April 2024) 
PDF Full Text (2939) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Review Article 
Breast surgery after neoadjuvant systemic therapy
Kate R. Pawloski, Andrea V. Barrio
Translational Breast Cancer Research  
2024;
5:
13  
(30 April 2024) 
PDF Full Text (2545) Peer Review File COI Form Open Access Get Permission
Review Article 
Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective
Billy Ho Hung Cheung, Michael Co, Tsz Tsun Natalie Lui, Ava Kwong
Translational Breast Cancer Research  
2024;
5:
12  
(30 April 2024) 
PDF Full Text (3892) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Review Article 
Internal mammary lymphadenopathy in breast cancer: a narrative review and update
Kathryn M. Eckert, Judy C. Boughey, Mara A. Piltin
Translational Breast Cancer Research  
2024;
5:
11  
(30 April 2024) 
PDF Full Text (3391) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Review Article 
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer
Eleonora Nicolò, Caterina Gianni, Letizia Pontolillo, Mara Serena Serafini, Laura Sofia Munoz-Arcos, Eleni Andreopoulou, Giuseppe Curigliano, Carolina Reduzzi, Massimo Cristofanilli
Translational Breast Cancer Research  
2024;
5:
10  
(30 April 2024) 
PDF Full Text (3220) Peer Review File COI Form Open Access Get Permission
Expert Consensus 
Expert consensus on the clinical application of immunotherapy in breast cancer: 2024
Kun Wang, Jin Yang, Biyun Wang, Qiang Liu, Xiaojia Wang, Yongmei Yin, Haibo Wang, Shusen Wang, Chunfang Hao, Xiaopeng Hao, Yueping Liu, Zefei Jiang; Chinese Society of Clinical Oncology Breast Cancer Committee
Translational Breast Cancer Research  
2024;
5:
9  
(30 April 2024) 
PDF Full Text (3697) Peer Review File COI Form Open Access Get Permission
Case Report 
A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer
Ye Lv, Huiqiang Zhang, Yanjiao Zhao, Haixia Zhang, Tao Wang
Translational Breast Cancer Research  
2024;
5:
8  
(31 January 2024) 
PDF Full Text (1264) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Case Report 
Poland syndrome combined with breast cancer: a case report
Shiqi Guo, Yuhui Chen, Qingyang Li, Yujiao Xie, Xiaopeng Hao, Jiandong Wang
Translational Breast Cancer Research  
2024;
5:
7  
(31 January 2024) 
PDF Full Text (1232) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Brief Report 
Can Hounsfield units on chest CT characterize breast nodules as cystic or solid?
Kathleen Capaccione, Elise Desperito, Arnold Caleb Asiimwe, Mary Salvatore
Translational Breast Cancer Research  
2024;
5:
6  
(31 January 2024) 
PDF Full Text (2048) Peer Review File COI Form Open Access Get Permission
Editorial Commentary 
Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
Zhigang Yu
Translational Breast Cancer Research  
2024;
5:
5  
(31 January 2024) 
PDF Full Text (889) Peer Review File COI Form Open Access Get Permission
Review Article 
Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives
Mahira Lopes Rosa, Tomas Reinert, Maiane Maria Pauletto, Guilherme Sartori, Marcia Graudenz, Carlos Henrique Barrios
Translational Breast Cancer Research  
2024;
5:
4  
(31 January 2024) 
PDF Full Text (3601) Peer Review File COI Form Open Access Get Permission
Review Article 
Challenges in HER2-low breast cancer identification, detection, and treatment
Qian Wu, Ling Xu
Translational Breast Cancer Research  
2024;
5:
3  
(31 January 2024) 
PDF Full Text (3154) Peer Review File COI Form Open Access Get Permission
Review Article 
Narrative review on advancing breast cancer treatment: harnessing the power of PD-1/PD-L1 inhibitors for improved patient outcomes
Fan Zhang, Shu-Sen Wang
Translational Breast Cancer Research  
2024;
5:
2  
(31 January 2024) 
PDF Full Text (1793) Reporting Checklist COI Form Open Access Get Permission
Review Article 
TORCHLIGHT trial, brightening the life of more patients with advanced triple-negative breast cancer
Huiqiang Zhang, Xiao Jin, Li Bian
Translational Breast Cancer Research  
2024;
5:
1  
(31 January 2024) 
PDF Full Text (1598) Peer Review File COI Form Open Access Get Permission
Case Report 
CDK4/6 inhibitors for primary endocrine resistant HR-positive/HER2-negative metastatic breast cancer: a case report
Ting Luo, Kunrui Zhu, Xiaorong Zhong, Ping He, Xi Yan, Tinglun Tian
Translational Breast Cancer Research  
2023;
4:
33  
(31 October 2023) 
PDF Full Text (1949) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Editorial 
Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR+HER2− metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China
Nino Balanchivadze, Nicholas J. Robert
Translational Breast Cancer Research  
2023;
4:
32  
(31 October 2023) 
PDF Full Text (1265) Peer Review File COI Form Open Access Get Permission
Editorial 
Navigating next-generation HR+/HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression
Patrick Neven, Lieke Dullens, Sileny Han, Anne Deblander, Yannick Van Herck, Maxime Van Houdt, Hans Wildiers
Translational Breast Cancer Research  
2023;
4:
31  
(31 October 2023) 
PDF Full Text (1574) Peer Review File COI Form Open Access Get Permission